CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Value of FDG-PET as a Supporting Biomarker for Dementia with Lewy Bodies at Stages of Early Dopaminergic Loss
DOI 10.1055/s-0040-1708403
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Beyer, M Huber, BS Rauchmann, S Morbelli, R Bruffaerts, R Vandenberghe, N Nicastro, AW Lemstra, S Garcia-Ptacek, MA Ochoa Figueroa, J Vöglein, R Perneczky, P Bartenstein, M Ewers, A Danek, J Levin, D Aarsland, FM Nobili, A Rominger, M Brendel
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Value of FDG-PET as a Supporting Biomarker for Dementia with Lewy Bodies at Stages of Early Dopaminergic Loss
Zitieren
Zitierempfehlung
L Beyer, M Huber, BS Rauchmann, S Morbelli, R Bruffaerts, R Vandenberghe, N Nicastro, AW Lemstra, S Garcia-Ptacek, MA Ochoa Figueroa, J Vöglein, R Perneczky, P Bartenstein, M Ewers, A Danek, J Levin, D Aarsland, FM Nobili, A Rominger, M Brendel (2020) Value of FDG-PET as a Supporting Biomarker for Dementia with Lewy Bodies at Stages of Early Dopaminergic Loss. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708403
Mit CareLit weiterarbeiten